Ligand Pharmaceuticals Inc. Says Roche Terminates Agreement

November 24, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Nov 23 (Reuters) - Ligand Pharmaceuticals Inc (LGNDD.O) said Swiss drugmaker Roche Holding AG (ROG.VX) was exercising its right to terminate the collaboration and license agreement between the two companies on developing hepatitis C treatment.

Twitter
LinkedIn
Facebook
Email
Print

Alliances Europe

Roche